SCHEMBL4381574

SCHEMBL4381574

CC(C(=O)O)c1cc(O)cc(O)c1-c1ccc2ccccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.51
AKR1C2 P52895 3/20 0.51
ACMSD Q8TDX5 1/20 0.44
PTGS2 P35354 2/20 0.42
PTGS1 P23219 1/20 0.42
ESR1 P03372 1/20 0.41
ESR2 Q92731 1/20 0.41
ALOX5 P09917 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
SOS1 Q07889 1/20 0.40
HIF1A Q16665 1/20 0.40
AKR1B1 P15121 2/20 0.40
S1PR4 O95977 1/20 0.40
S1PR5 Q9H228 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL599428 0.74 AKR1C3 (0.55) AKR1C3AKR1C2PTGS2CYP1A2CYP2D6
SCHEMBL8451518 0.72 PTGS2 (0.71) AKR1C3AKR1C2PTGS2PTGS1CYP1A2
SCHEMBL12431128 0.71 AKR1B1 (0.69) AKR1C3AKR1C2PTGS2PTGS1CYP1A2
SCHEMBL4679446 0.71 AKR1B1 (0.69) AKR1C3AKR1C2PTGS2PTGS1CYP1A2
SCHEMBL10025981 0.71 AKR1B1 (0.69) AKR1C3AKR1C2PTGS2PTGS1CYP1A2
SCHEMBL30717241 0.71 AKR1B1 (0.69) AKR1C3AKR1C2PTGS2PTGS1CYP1A2
SCHEMBL1217681 0.71 AKR1B1 (0.69) AKR1C3AKR1C2PTGS2PTGS1CYP1A2
Hydrochloric Acid SCHEMBL27401798 0.70 AKR1B1 (0.67) AKR1C3AKR1C2PTGS2PTGS1CYP1A2
SCHEMBL23070750 0.69 AKR1C3 (0.74) AKR1C3AKR1C2PTGS2PTGS1CYP1A2
SCHEMBL6025217 0.68 CCNC (0.45) ACMSDESR1ESR2ALOX5HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7538241-B2 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-05-26 US disclosed
US-20070155813-A1 Hsp90 family protein inhibitors KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155813-A1 Hsp90 family protein inhibitors HSP90AB1, HEATR1, HSP90AB2P AKR1C3 1516/4885AKR1C2 1443/4885ACMSD 4292/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.